ABUS icon

Arbutus Biopharma

91 hedge funds and large institutions have $87.5M invested in Arbutus Biopharma in 2021 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 22 increasing their positions, 25 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership:

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

14% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 22

44% less call options, than puts

Call options by funds: $2.76M | Put options by funds: $4.95M

Holders
91
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.76M
Puts
$4.95M
Net Calls
Net Calls Change

Top Buyers

1 +$11.3M
2 +$3.33M
3 +$2.74M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.28M
5
Northern Trust
Northern Trust
Illinois
+$1.78M

Top Sellers

1 -$3.35M
2 -$2.54M
3 -$1.77M
4
Millennium Management
Millennium Management
New York
-$1.74M
5
Two Sigma Investments
Two Sigma Investments
New York
-$1.56M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$18.1M
2
$17.7M
3
$11.3M
4
$5.45M
5
$4.15M
6
$3.9M
7
$3.5M
8
$3.03M
9
$2.18M
10
$1.51M
11
$1.41M
12
$1.14M
13
$1.05M
14
$1.03M
15
$884K
16
$796K
17
$781K
18
$769K
19
$765K
20
$727K
21
$685K
22
$681K
23
$565K
24
$361K
25
$336K